FDFrancisca Stutzin Donoso

Francisca Stutzin Donoso

*This is an algorithmically generated author record based on publicly available information.

Francisca Stutzin Donoso has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Towards a public-facing version of the CanRisk tool: Co-designing, developing and evaluating MyCanRisk

    by Cameron Wilson, Francisca Stutzin Donoso, Juliet A. Usher-Smith, Nichola Fennell, Lorenzo Ficorella, Fiona M. Walter, Jon Emery, Douglas F. Easton, Marc Tischkowitz, Antonis C. Antoniou, et al.

    The CanRisk tool allows healthcare professionals to calculate validated multifactorial estimates of breast, ovarian, and prostate cancer risk. To support patient involvement in risk assessment, we co-designed a public-facing tool, MyCanRisk, which allows patients to collect and share risk information in advance of a clinical appointment, without generating risk estimates. This study describes the user-centred development of MyCanRisk and its initial evaluation. Development involved co-design workshops with patients, public contributors, healthcare professionals, and researchers, followed by iterative accessibility and usability testing against WCAG 2.2. Evaluation used a multi-methods design: 51 women with a family history of breast cancer completed MyCanRisk and, approximately two weeks later, a structured clinical-style interview. Agreement in risk categorisation was assessed using Cohen’s kappa. Semi-structured interviews with a purposive subsample (n=15) explored user experiences. MyCanRisk was perceived as accessible and easy to use. Agreement between MyCanRisk and structured interviews for risk categorisation was substantial (κ = 0.81, 95% CI 0.65–0.97). Discrepancies mainly reflected difficulties recalling detailed family history, such as ages at diagnosis and dates of birth/death. Participants valued the stepwise flow and asynchronous completion but reported challenges when their knowledge was incomplete. Suggested improvements included options to record approximate or unknown data and greater flexibility to update submissions. MyCanRisk has the potential to reduce data collection burden during clinical encounters, support patient preparation for risk assessment, and streamline cancer risk assessment pathways. With further refinement and testing in more diverse populations, it may facilitate earlier identification of individuals at increased cancer risk.

  • Open Access

    CanRisk-GP protocol: A feasibility study of incorporating proactive multifactorial breast cancer risk assessment into general practice

    by Francisca Stutzin Donoso, Stephanie Archer, Fiona M. Walter, Stephen Morris, Jon Emery, Jack Broome, Tim Carver, Joe Dennis, Lorenzo Ficorella, Amy Lafont, et al.

    Background: CanRisk is a risk assessment tool that implements the BOADICEA multifactorial breast cancer risk model. The BOADICEA model is recommended for use by the National Institute for Health and Care Excellence (NICE) in English, Welsh, and Northern Irish secondary/tertiary care to identify women who may be at moderate or high risk of developing breast cancer. BOADICEA combines information on cancer family history, demographic, lifestyle, hormonal risk factors and mammographic density with polygenic scores (PGS). Offering risk assessment using CanRisk in general practice has the potential to identify more women at moderate or high risk of developing breast cancer and improve their management and the appropriateness of referrals to secondary/tertiary care. Materials and methods: In this feasibility study we plan to invite women aged 40–49 years from 5–8 practices across Cambridgeshire and Peterborough in England, UK to complete a breast cancer risk assessment using CanRisk via a newly developed public-facing version of the CanRisk tool and provide saliva samples for PGS. The study team will provide a risk report back to both the participants and their GP, with those women at above-population level risk advised to make an appointment with their GP to be referred to the clinical genetics service and subsequently managed in line with current NICE guidelines. This study will provide evidence on (1) whether offering cancer risk assessment including PGS in general practice is feasible and acceptable to women and healthcare professionals; (2) whether this approach can identify women at above-population level risk of breast cancer who would otherwise not have been identified and so not had access to risk-reducing options; and (3) the costs associated with implementing proactive multifactorial breast cancer risk assessment in women under 50 within general practice. Study registration number: This study is listed on the ISRCTN registry. The registration number is ISRCTN17376192.


  • Open Access

    Primary care online training on multifactorial breast cancer risk: pre–post evaluation study

    by Francisca Stutzin Donoso, Juliet A Usher-Smith, Lorenzo Ficorella, Antonis C Antoniou, Jon Emery, Marc Tischkowitz, Tim Carver, Douglas F Easton, Fiona M Walter, Stephanie Archer

    Background: It is estimated that more than 250 000 women in the UK are at increased risk of breast cancer, but only a small fraction are identified. Digital tools, such as CanRisk, enable multifactorial breast cancer risk assessment. Implementation of such tools within primary care would allow primary care professionals (PCPs) to reassure women at population-level risk and identify those at increased risk who will benefit most from targeted prevention or early detection. Previous studies suggest that PCPs will require educational resources to support the delivery of multifactorial breast cancer risk assessments. Aim: To develop and evaluate a new ‘Multifactorial breast cancer risk assessment in primary care’ online training for UK PCPs. Design & setting: A mixed-methods pre–post evaluation study was undertaken. Thirty-five PCPs from across the UK participated in the evaluation and data collection was completed online between May and July 2024. Method: The online training was developed following a scoping review of the literature. The Kirkpatrick model of training evaluation was used as a framework and participants were given pre-training and post-training evaluation questionnaires. Statistical analysis for the evaluation focused on the primary outcome of objective knowledge and mean changes were analysed with a paired sample t -test. Qualitative feedback was analysed using content analysis. Results: Objective knowledge showed a significant mean increase (0.771, 95% confidence interval [CI] = 0.187 to 1.355, P = 0.011). Subjective knowledge and confidence scores also showed significant mean increases (6.828, 95% CI = 5.150 to 8.506, P P <0.001, respectively). Results on satisfaction, engagement, and relevance of the training were positive. Conclusion: The ‘Multifactorial breast cancer risk assessment in primary care’ online training significantly increases PCPs’ knowledge and confidence to conduct multifactorial breast cancer risk assessments, and it was well received by PCPs.


  • Open Access

    From Self-Management to Shared-Management: A Relational Approach for Equitable Chronic Care

    by Francisca Stutzin Donoso

    Much of the academic literature on chronic disease argues that failure to adjust to chronic disease is strongly associated with poor self-management (SM)—mainly understood as adherence to long-term treatment 1, so there is a strong focus on self-management support (SMS) in chronic care ( Bodenheimer et al., 2002; Ridder et al., 2008).A comprehensive review from 2003 conducted by experts from the World Health Organization (WHO) reported that adherence to long-term treatments was around 50 per cent in high-income countries and presumably comparable or lower in low-and-middle income countries, contributing to the high rates of premature death and poor individual and population health outcomes ( Sabaté, 2003). Even though this report has not been updated, recent systematic reviews about this issue continue to report sub-optimal adherence worldwide, adding a possible social gradient in long-term treatment adherence ( Ortego et al., 2011; Gast and Mathes, 2019; Ogungbe et al., 2021).


  • Open Access

    Exploring the barriers to and facilitators of implementing CanRisk in primary care: a qualitative thematic framework analysis

    by Stephanie Archer, Francisca Stutzin Donoso, Tim Carver, Adelaide Yue, Alex P Cunningham, Lorenzo Ficorella, Marc Tischkowitz, Douglas F Easton, Antonis C Antoniou, Jon Emery, et al.

    Background: The CanRisk tool enables the collection of risk factor information and calculation of estimated future breast cancer risks based on the multifactorial Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) model. Despite BOADICEA being recommended in National Institute for Health and Care Excellence (NICE) guidelines and CanRisk being freely available for use, the CanRisk tool has not yet been widely implemented in primary care.Aim: To explore the barriers to and facilitators of the implementation of the CanRisk tool in primary care.Design and setting: A multi-methods study was conducted with primary care practitioners (PCPs) in the East of England.Method: Participants used the CanRisk tool to complete two vignette-based case studies; semi-structured interviews gained feedback about the tool; and questionnaires collected demographic details and information about the structural characteristics of the practices.Results: Sixteen PCPs (eight GPs and eight nurses) completed the study. The main barriers to implementation included: time needed to complete the tool; competing priorities; IT infrastructure; and PCPs’ lack of confidence and knowledge to use the tool. Main facilitators included: easy navigation of the tool; its potential clinical impact; and the increasing availability of and expectation to use risk prediction tools.Conclusion: There is now a greater understanding of the barriers and facilitators that exist when using CanRisk in primary care. The study has highlighted that future implementation activities should focus on reducing the time needed to complete a CanRisk calculation, integrating the CanRisk tool into existing IT infrastructure, and identifying appropriate contexts in which to conduct a CanRisk calculation. PCPs may also benefit from information about cancer risk assessment and CanRisk-specific training.


  • Open Access

    Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial

    by Stephanie Archer, Nichola Fennell, Ellen Colvin, Rozelle Laquindanum, Meredith Mills, Romy Dennis, Francisca Stutzin Donoso, Rochelle Gold, Alice Fan, Kate Downes, et al.

    Women who test positive for an inherited pathogenic/likely pathogenic gene variant in BRCA1, BRCA2, PALB2, CHEK2 and ATM are at an increased risk of developing certain types of cancer—specifically breast (all) and epithelial ovarian cancer (only BRCA1, BRCA2, PALB2). Women receive broad cancer risk figures that are not personalised (e.g., 44–63% lifetime risk of breast cancer for those with PALB2). Broad, non-personalised risk estimates may be problematic for women when they are considering how to manage their risk. Multifactorial-risk-prediction tools have the potential to deliver personalised risk estimates. These may be useful in the patient’s decision-making process and impact uptake of risk-management options. This randomised control trial (registration number to follow), based in genetic centres in the UK and US, will randomise participants on a 1:1 basis to either receive conventional cancer risk estimates, as per routine clinical practice, or to receive a personalised risk estimate. This personalised risk estimate will be calculated using the CanRisk risk prediction tool, which combines the patient’s genetic result, family history and polygenic risk score (PRS), along with hormonal and lifestyle factors. Women’s decision-making around risk management will be monitored using questionnaires, completed at baseline (pre-appointment) and follow-up (one, three and twelve months after receiving their risk assessment). The primary outcome for this study is the type and timing of risk management options (surveillance, chemoprevention, surgery) taken up over the course of the study (i.e., 12 months). The type of risk-management options planned to be taken up in the future (i.e., beyond the end of the study) and the potential impact of personalised risk estimates on women’s psychosocial health will be collected as secondary-outcome measures. This study will also assess the acceptability, feasibility and cost-effectiveness of using personalised risk estimates in clinical care.


  • Open Access

    Understanding the problem of long-term treatment adherence: a phenomenological framework

    by Francisca Stutzin Donoso

    In light of the large burden of chronic disease and the low rates of long-term treatment adherence contributing to high rates of morbidity and mortality worldwide, this paper contributes to better understanding the particular kind of challenge that living with chronic illness and adhering to long-term treatment can imply. Both literature on the concept of chronic disease and the experience of illness suggest going outside specific diagnostic categories to better understand the problem of adherence. After introducing the distinction of a thin understanding of chronicity—merely as long duration—and a thick one—chronicity in a phenomenological sense, this paper analyses academic literature on the experience of illness and specifies it to the case of chronic diseases, introducing an original conceptual framework describing some main challenges arising from the experience of chronic disease. The framework is organised in three dimensions: failing to recover as a failure to belong, being at a loss and breaking-up with oneself. This work suggests a particular subjective state in which struggling to follow long-term treatment may seem understandable and reasonable, offering a phenomenological perspective that feeds into the ethical problems arising in chronic diseases, and shedding light on how to increase adherence without reproducing patterns of disadvantage.


  • Open Access

    Use of health services among international migrant children – a systematic review

    by Niina Markkula, Baltica Cabieses, Venla Lehti, Eleonora Uphoff, Sofia Astorga, Francisca Stutzin

    Migrant children have specific health needs, and may face difficulties in accessing health care, but not enough is known about their health service use. This study aims to describe patterns of use of health services of international migrant children and differences to respective native populations. Electronic databases PubMed and Web of Science, references of identified publications, and websites of relevant international agencies were searched. We included observational studies published between 2006 and 2016 that reported use of formal health services by migrant children (0–18 years), including first and second generation migrants. Data on study characteristics, study theme, main outcome and study quality were extracted. One hundred seven full texts were included in the review. Of the studies that reported comparable outcomes, half (50%) indicated less use of healthcare by migrants compared with non-migrants; 25% reported no difference, 18% reported greater use, and 7% did not report this outcome. There was variation by theme, so that the proportion of conclusions “less use” was most common in the categories “general access to care”, “primary care” and “oral health”, whereas in the use of emergency rooms or hospitalisations, the most common conclusion was “greater use”. Migrant children appear to use different types of healthcare services less than native populations, with the exception of emergency and hospital services. PROSPERO systematic review registration number: CRD42016039876 .